medigraphic.com
ISSN 1561-2937 (Print)

2017, Number 2

<< Back

Rev Cubana Cardiol Cir Cardiovasc 2017; 23 (2)

Intimate carotid thickness and its relation with cardiovascular risk factors in the population of the municipality Plaza de la Revolution

Jerez CAM, Echevarría PS, Guevara MG, Aleaga CE, González TA

Language: Spanish
References: 52
Page:
PDF size: 305.54 Kb.


ABSTRACT

Non-compacted ventricular myocardiopathy (MVNC), currently considered a mitochondriopathy, is associated, in most cases, with inherited cardiac or skeletal muscle disease or with chromosomal abnormalities. Depending on the study, more than two-thirds of patients with MVNC also have a neuromuscular disease (NMS). A causal relationship between NMS and MVNC is likely, although the exact relationship and pathogenetic association remain elusive.


REFERENCES

  1. Chin TK, Perloff JK, Williams RG, et al. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990; 82:507-13.

  2. Engberding R, Bender F. Identification of a rare congenital anomaly of the myocardium by two-dimensional echocardiography: persistence of isolated myocardial sinusoids. Am J Cardiol 1984; 53:1733-4.

  3. Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of theventricular myocardium. Circulation 2004; 109:2965-71.

  4. Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/non-compaction. J Am SocEchocardiogr 2004; 17:91-100.

  5. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90:899-902.

  6. Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular Hypertrabeculation/noncompaction. PediatrCardiol 2009;30:659-81.

  7. Stöllberger C, Finsterer J, Blazek G. Left ventricular hypertrabeculation / noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90:899-902.

  8. Stöllberger C, Finsterer J, Blazek G, Bittner RE. Left ventricular non-compaction in a patient with becker's muscular dystrophy.Heart 1996; 76: 380.

  9. Bleyl SB, Mumford BR, Thompson V, et al. Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. Am J Hum Genet 1997; 61: 868-72.

  10. Finsterer J, Stöllberger C. Hypertrabeculated left ventricle in mito- chondriopathy. Heart 1998; 80: 632.

  11. Ichida F, Tsubata S, Bowles KR, et al. Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome.Circulation 2001; 103: 1256-63.

  12. Finsterer J, Stöllberger C, Wegmann R, et al. Left ventricular hypertrabeculation in myotonic dystrophy type 1. Herz 2001; 26: 287-90.

  13. Vatta M, Mohapatra B, Jimenez S, et al. Mutations in cypher/ZASP in patients with dilated cardiomyopathy and left ven-tricular non-compaction. J Am CollCardiol 2003; 42: 2014-27.

  14. Hermida-Prieto M, Monserrat L, Castro-Beiras A, et al. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C gene mutations. Am J Cardiol 2004; 94:50-4.

  15. Finsterer J, Gelpi E, Stöllberger C. Left ventricular hypertrabeculation / noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation. ActaCardiol 2005; 60: 445-8.

  16. Finsterer J, Schoser B, Stöllberger C. Myoadenylate-deaminasegene mutation associated with left ventricular hypertrabeculation/non-compaction. ActaCardiol 2004; 59: 453-6.

  17. Corrado G, Checcarelli N, Santarone M, Stollberger C, Finsterer J.Left ventricular hypertrabeculation/noncompaction with PMP22duplication-based Charcot-Marie-Tooth disease type 1A. Cardiology 2006; 105: 142-5.

  18. Wahbi K, Meune C, Bassez G, et al. Left ventricular noncompaction in a patient with myotonic dystrophy type 2. NeuromusculDisord 2008; 18: 331-3.

  19. Finsterer J, Stöllberger C, Höftberger R. Left ventricular hypertrabeculation / noncompaction in hereditary inclusion body myopathy. Int J Cardiol 2009; (in press).

  20. Lau TK, Flamm SD, Stainback RF. Noncompaction of the ventricular myocardium. Circulation. 2002;105:e57. 21. Stöllberger C, Steger C, Finsterer J. Myopathy, left ventricular noncompaction, and tetralogy of Fallot. ClinCardiol 2009;32:E46-8.

  21. Ramineni R, Merla R, Chernobelsky A. Noncompaction of ventricular myocardium associated with hypertrophic cardiomyopathy and polycystic kidney disease. Am J Med Sci2010;(in press).

  22. Stöllberger C, Stix A, Finsterer J. Overreaction to noncompaction in a patient with ankylosing spondylitis, Parkinson disease, migraine and myopathy. Int J Cardiol2009;(in press).

  23. Sweeney RT, Davis GJ, Noonan JA. Cardiomyopathy of unknown etiology: Barth syndrome unrecognized. Congenit Heart Dis 2008;3:443-8.

  24. Finsterer J, Stöllberger C, Feichtinger H. Noncompaction and endocarditis in suspected mitochondrial disorder. Int J Cardiol 2008;123:e45-7.

  25. María P. Velazco, Gabriela S. Ranchilio, et al. Miocardio no compactado y esferocitosis hereditaria. Un caso clínico. Rev. Argent. Cardiol. v.76 n.1 Buenos Aires ene./feb. 2008

  26. Samuel T. Brescia, Joseph W. Rossano, Ricardo Pignatelli. Mortality and Sudden Death in Pediatric Left Ventricular Noncompaction in a Tertiary Referral Center. Circulation. 2013;127:2202-2208; originally published online April 30, 2013; http://circ.ahajournals.org/content/127/22/2202

  27. Tsai SF, Ebenroth ES, Hurwitz RA, Cordes TM, Schamberger MS, Batra AS. Is left ventricular noncompaction in children truly an isolated lesion? PediatrCardiol. 2009;30:597---602.

  28. Kitao K, Ohara N, Funakoshi T, Moriyama T, Maruo T, Yamane M, et al. Noncompaction of the left ventricular myocardium diagnosed in pregnant woman and neonate. J Perinat Med. 2004;32:527---31.

  29. Sabaté, Rotés A, V.M. Huertas-Quiñones B, P. Betrián A. Miocardiopatía no compactada: características clínicas, evolutivas y pronosticas en edad pediátrica. Resultados de un estudio multicéntrico. AnPediatr (Barc). 2012;77(6):360---365. www.elsevier.es/anpediatrica.

  30. P Martínez-Losas, E. Enríquez-Rodríguez, D. Vivas y M. Luaces Instituto Cardiovascular, Hospital Clínico San Carlos, Madrid, España. Semergen. 2015;41(5):e41---e43 http://dx.doi.org/10.1016/j.semerg.2014.08.001

  31. Stölberger C, Finsterer J, Blazek G: Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002; 90: 899-902

  32. Riter M, Oechslin E, Sutsch G y col: Isolated noncompaction of the myocardium in adults. Mayo ClinProc 1997; 7: 26-31.

  33. Barisani José Luis, Ubaldini Jorge, Sampó Eduardo, et al .Consenso de Diagnóstico y Tratamiento de la Insuficiencia Cardíaca Crónica. Federación Argentina de Cardiología 2010.

  34. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 1987;316:1429-35.

  35. Willenheimer R, Van Veldhuisen DJ, Silke B, et al; CIBIS III Investigators. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: Results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation 2005;112:2426-35.

  36. Granger CB, McMurray JJ, Yusuf S, et al; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced leftventricular systolic function intolerant to angiotensin-convertingenzyme inhibitors: The CHARM-Alternative trial. Lancet 2003; 362:772-6.

  37. Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale design, and baseline patient characteristics. J Card Fail 2004;10:101-12.

  38. Wilson JR, Reichek N, Dunkman WB, et al. Effect of diuresis on the performance of the failing left ventricle in man. Am J Med 1981;70:234-9.

  39. Fox K, Ford I, Steg PG, et al; BEAUTIFUL Investigators. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial. Lancet 2008; 372:807-16.

  40. Russo AM, Stainback RF, Bailey SR, et al. ACCF / HRS / AHA / ASE / HFSA / SCAI / SCCT / SCMR 2013. Appropriate Use Criteria for Implantable Cardioverter- Defibrillators and Cardiac Resynchronization Therapy. J Am CollCardiol 2013; 61: 1323-73.

  41. Steffel J, Duru F. Rhythm disorders in isolated left ventricular noncompaction. Ann Med 2012; 44 (2): 101-8.

  42. Néstor O. Galizio, José l. González, Liliana E. Favaloro, Mirta Diez. Miocardiopatía no compactada. Estratificación de riesgo de muerte súbita para indicación de cardiodesfibrilador automático implantable. Revista argentina de cardiología versión ISSN 1850-3748. Cardiol. vol.79 no.1 Ciudad Autónoma de Buenos Aires ene./feb. 2011

  43. Epstein AE, DiMarco JP, Ellenbogen KA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117(21):e350-408.

  44. Oscar A Pellizzón, Liliana Gastaldi, Juan M Bonelli, et al. Trastornos del ritmo cardíaco en ventrículo izquierdo no compactado aislado. Breve revisión de la literatura a propósito de una casuística.Rev Fed ArgCardiol. 2015; 44(1): 57-61

  45. Kobza R, Steffel J, Erne P, et al. Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompaction. Heart Rhythm 2010; 7: 1545-9.

  46. Stanton C, Bruce C, Connolly H, et al. Isolated left ventricular noncompaction syndrome. Am J Cardiol 2009; 104: 1135-8.

  47. Epstein AE, Di Marco JP, Ellenbogen KA, et al. 2012 ACCF / AHA / HRS Focused Update Incorporated Into the ACCF / AHA / HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities. Circulation 2013; 127: e283-e352.

  48. Ritter M, Oechslin E, Sütsch G, et al. Isolated noncompaction of the myocardium in adults. Mayo Clinic Proc1997;72:26-31.[Abstract/FREE Full text]

  49. Oechslin E.N, AttenhoferJost C.H, Rojas J.R, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am CollCardiol, 2000. 36(2): p. 493-500.

  50. Lofiego, C, Biagini, E, Pasquale, F, et al., Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart, 2007. 93(1): p. 65-71.

  51. McMahon, C.J, Pignatelli, R.H, Nagueh, S.F, et al. Left ventricular non-compaction cardiomyopathy in children: characterisation of clinical status using tissue Doppler-derived indices of left ventricular diastolic relaxation. Heart, 2007. 93(6): p. 676-81.

  52. Nucifora, G, Aquaro, G.D, Pingitore, A, et al., Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail, 2011. 13(2): p. 170-6.




2020     |     www.medigraphic.com